Evidence map›Paper›PMID 29626121›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

Reproducibility and Repeatability of Semiquantitative

Hebert Alberto Vargas, Gem M Kramer, Andrew M Scott, Andrew Weickhardt, Andreas A Meier, Nicole Parada, Bradley J Beattie, John L Humm, Kevin D Staton, Pat B Zanzonico and 17 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Repeatability of QuantitativeJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Trial
  2. NonsteroidalJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Article
  4. Targeting RIPK1 to modulate cell death and tumour microenvironment in cancer therapy.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  5. Article
  6. Review
  7. [Diagnostics (Basel, Switzerland) · 2023
    Review
  8. Review
  9. Review
  10. Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  11. Review
  12. IdentifyingQuantitative imaging in medicine and surgery · 2022
    Article
  13. An optimized imaging protocol for [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  14. Review
  15. Review
  16. Review
  17. Multimodality Imaging of Prostate Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Review
  18. Assessment of Simplified Methods for Quantification ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Observational
  19. Healthy Tissue Uptake ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  20. Sensitivity ofEJNMMI research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 4 countries.

Hebert Alberto VargasDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York vargasah@mskcc.org.
Gem M KramerDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Andrew M ScottDepartment of Molecular Imaging and Therapy, The University of Melbourne, Heidelberg, Victoria, Australia.
Andrew WeickhardtDepartment of Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Hospital, Melbourne, Victoria, Australia.
Andreas A MeierDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nicole ParadaDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Bradley J BeattieDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
John L HummDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Kevin D StatonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Pat B ZanzonicoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Serge K LyashchenkoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jason S LewisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Maqsood YaqubDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Ramon E SosaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Alfons J van den EertweghDepartment of Medical Oncology, VU University Medical Centre, Amsterdam, The Netherlands.
Ian D DavisMonash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia.
Uwe AckermannDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
Kunthi PathmarajDepartment of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
Robert C SchuitDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Albert D WindhorstDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Sue ChuaDepartment of Nuclear Medicine, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; and.
Wolfgang A WeberDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Steven M LarsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Howard I ScherDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Adriaan A LammertsmaDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Otto S HoekstraDepartment of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Michael J MorrisDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Memorial Sloan Kettering Cancer Center · USAmsterdam UMC Location VUmc · NLAustin Health · AUCornell University · USWeill Cornell Medicine · USAustin Hospital · AUEastern Health · AUOlivia Newton-John Cancer Wellness & Research Centre · AURoyal Marsden NHS Foundation Trust · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorine RadioisotopesAgedAged, 80 and overBiological TransportDihydrotestosteroneHumansImage Processing, Computer-AssistedMaleMiddle AgedNeoplasm MetastasisPositron Emission Tomography Computed TomographyProspective StudiesProstatic Neoplasms, Castration-ResistantReproducibility of Results16-fluorodihydrotestosteroneDihydrotestosteroneFluorine-18Fluorine RadioisotopesFDHTPETprostate cancerrepeatabilityreproducibility

Identifiers

PMID29626121
PMCPMC6167532
OpenAlexW2796034875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.